{
    "code": "52026657",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026657",
    "time": "2021-02-19 05:20:16",
    "許可證字號": "衛部藥輸字第026657號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/03\/07",
    "發證日期": "105\/03\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202665703",
    "中文品名": "&quot;吸必擴&quot;氣化噴霧劑 160\/4.5 微克\/劑量",
    "英文品名": "Symbicort Rapihaler 160\/4.5ug\/dose",
    "適應症": "氣喘(Asthma)\r\nSymbicort Rapihaler適用於適合使用吸入型皮質類固醇及長效β2作用劑(β2- agonist)合併治療的氣喘(asthma)常規治療。\r\n-以吸入型皮質類固醇和“需要時”吸入短效β2作用劑未能充分控制氣喘的病人\r\n慢性阻塞性肺部疾病(COPD)\r\nSymbicort Rapihaler適用於患有中至重度COPD，頻繁出現症狀及有惡化病史之病人的常規治療。",
    "劑型": "303氣化噴霧劑",
    "包裝": "100毫升以下鋁罐裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE",
    "限制項目": "02輸　入 26監視期滿新藥",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號21樓",
    "主製造廠": [
        {
            "製造廠名稱": "FFR0195000  ASTRAZENECA DUNKERQUE PRODUCTION",
            "製造廠廠址": "224, AVENUE DE LA DORDOGNE (B.P. 41), 59640 DUNKERQUE CEDEX  2, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216003030",
            "成分名稱": "FORMOTEROL FUMARATE DIHYDRATE",
            "含量描述": "",
            "含量": "4.5000000000",
            "單位": "ug"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8406002100",
            "成分名稱": "BUDESONIDE",
            "含量描述": "",
            "含量": "160.0000000000",
            "單位": "ug"
        }
    ],
    "仿單外盒": [
        {
            "title": "Symbicort Rapihaler 160 4.5 中文仿單 2018-108-04-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026657&Seq=004&Type=9"
        },
        {
            "title": "衛部藥輸字第026657號-吸必擴氣化噴霧劑160 4.5微克劑量-仿單-107-10-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026657&Seq=003&Type=9"
        },
        {
            "title": "6-Symbicort Rapihaler 160 4.5 - 吸必擴氣化噴霧劑中文外盒-105-04-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026657&Seq=001&Type=8"
        }
    ]
}